Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases

Simona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sc...

Full description

Bibliographic Details
Main Authors: Serini S, Cassano R, Trombino S, Calviello G
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/nanomedicine-based-formulations-containing-omega-3-polyunsaturated-fat-peer-reviewed-article-IJN
_version_ 1818897755238563840
author Serini S
Cassano R
Trombino S
Calviello G
author_facet Serini S
Cassano R
Trombino S
Calviello G
author_sort Serini S
collection DOAJ
description Simona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sciences, Università della Calabria, 87036 Cosenza, Italy *These authors contributed equally to this work Abstract: Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are dietary factors involved in the prevention of cardiovascular, inflammatory, and neoplastic diseases. A multidisciplinary approach – based on recent findings in nutritional science, lipid biochemistry, biotechnology, and biology of inflammation and cancer – has been recently employed to develop ω-3 PUFA-containing nanoformulations with an aim to protect these fatty acids from degradation, increase their bioavailability and delivery to target tissues, and, thus, enhance their bioactivity. In some cases, these nanoformulations were designed to administer ω-3 PUFAs in combination with other nutraceuticals or conventional/innovative drugs. The aim of this strategy was to increase the activities of the compounds contained in the nanoformulation and to reduce the adverse effects often induced by drugs. We herein analyze the results of papers evaluating the potential use of ω-3 PUFA-containing nanomaterials in fighting cardiovascular diseases and cancer. Future directions in this field of research are also provided. Keywords: innovative biotechnologies, cardiovascular diseases, nanoparticles, ω-3 PUFAs, cancer  
first_indexed 2024-12-19T19:21:13Z
format Article
id doaj.art-d876efa9bed84aaa9e047765768c9672
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-19T19:21:13Z
publishDate 2019-04-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-d876efa9bed84aaa9e047765768c96722022-12-21T20:08:59ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-04-01Volume 142809282845280Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseasesSerini SCassano RTrombino SCalviello GSimona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sciences, Università della Calabria, 87036 Cosenza, Italy *These authors contributed equally to this work Abstract: Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are dietary factors involved in the prevention of cardiovascular, inflammatory, and neoplastic diseases. A multidisciplinary approach – based on recent findings in nutritional science, lipid biochemistry, biotechnology, and biology of inflammation and cancer – has been recently employed to develop ω-3 PUFA-containing nanoformulations with an aim to protect these fatty acids from degradation, increase their bioavailability and delivery to target tissues, and, thus, enhance their bioactivity. In some cases, these nanoformulations were designed to administer ω-3 PUFAs in combination with other nutraceuticals or conventional/innovative drugs. The aim of this strategy was to increase the activities of the compounds contained in the nanoformulation and to reduce the adverse effects often induced by drugs. We herein analyze the results of papers evaluating the potential use of ω-3 PUFA-containing nanomaterials in fighting cardiovascular diseases and cancer. Future directions in this field of research are also provided. Keywords: innovative biotechnologies, cardiovascular diseases, nanoparticles, ω-3 PUFAs, cancer  https://www.dovepress.com/nanomedicine-based-formulations-containing-omega-3-polyunsaturated-fat-peer-reviewed-article-IJNInnovative biotechnologiesCardiovascular diseasesNanoparticlesω-3 PUFAsCancer
spellingShingle Serini S
Cassano R
Trombino S
Calviello G
Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
International Journal of Nanomedicine
Innovative biotechnologies
Cardiovascular diseases
Nanoparticles
ω-3 PUFAs
Cancer
title Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_full Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_fullStr Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_full_unstemmed Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_short Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_sort nanomedicine based formulations containing omega 3 polyunsaturated fatty acids potential application in cardiovascular and neoplastic diseases
topic Innovative biotechnologies
Cardiovascular diseases
Nanoparticles
ω-3 PUFAs
Cancer
url https://www.dovepress.com/nanomedicine-based-formulations-containing-omega-3-polyunsaturated-fat-peer-reviewed-article-IJN
work_keys_str_mv AT serinis nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT cassanor nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT trombinos nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT calviellog nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases